BIVI

BioVie Inc. · NASDAQ · Healthcare · USD · 10-K for 2026, filed 2026-08-13

Figures on this page computed 2026-11-08 12:57 UTC

Last close

1.33USD

Market data, 2026-11-06

BIVI: weekly closes from 1.48 on 2025-11-07 to 1.33 on 2026-11-06, a move of -10.1%. Prices in USD.

Weekly closes, 2025-11-07 to 2026-11-06

Over that span: -10.1%

Except where said otherwise: 10-K for 2026, filed 2026-08-13

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- computed
- 10-K for 2026, filed 2026-08-13
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
The filing itself
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
The filing itself
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
The filing itself
0.03Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital is the furthest below its sector's middle: 0.04 against 0.20 on the market's range.

Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

n/a

0.73x

n/a

2.00x

0.00x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2026

Market data2026-11-06

Each against its own average

3 of 5 read

Except where said otherwise: 10-K for 2026, filed 2026-08-13

Salesn/a
Its own average over 0 years.
Profit0.73x
Its own average over 10 years, -30.1M.
Free cash flown/a
Its own average over 0 years.
Debt2.00x
Its own average over 5 years, 137.6K.
Price0.00x
Its own average over 11 years, 783. Market data, 2026-11-06

Debt is furthest from its own average, at 2.00 times.

The filed years, as a table

Each line is 100 at 2019-06-30, the first year we hold.

Filed year	Shares in issue
2019-06-30	100.0
2020-06-30	194.1
2021-06-30	488.4
2022-06-30	971.1
2023-06-30	1,279.1
2024-06-30	1,779.2
2025-06-30	5,817.3
2026-06-30	28,531.6

How shares in issue was got

Source: filed
Statement: income
Fiscal year: 2026
Accession: 0001520138-26-000332
Reported in: USD

The filing itself

Figures behind the shape

Growth

-25.8%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income-25.8%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

-214.9%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
The filing itself
Return on equity-214.9%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
The filing itself
Return on assets-154.9%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
The filing itself

Margins

n/a

We do not hold this figure for this company, so there is nothing to place.

wider is higher, with no cohort held

Gross marginn/a
We do not hold this figure for this company, so there is nothing to place.
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
The filing itself
Operating marginn/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
The filing itself
Net marginn/a
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
The filing itself
Free cash flow marginn/a
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
The filing itself

Price

0.9x

cheaper is higher, placed against 4,482 companies as of 2026-11-07

Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- computed
- 10-K for 2026, filed 2026-08-13
The filing itself
Price to book0.9x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- computed
- 10-K for 2026, filed 2026-08-13
- computed
- 10-K for 2026, filed 2026-08-13
The filing itself
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- computed
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
The filing itself
Price to sales ration/a
We do not hold this figure for this company, so there is nothing to place.
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- computed
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
The filing itself

Safety

0.03

safer is higher, placed against 4,231 companies as of 2026-11-07

Debt to equity0.03
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
The filing itself
Current ratio3.59
Current Assets / Current Liabilities
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
The filing itself
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
The filing itself
Altman Z-Scoren/a
We do not hold this figure for this company, so there is nothing to place.
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 10-K for 2026, filed 2026-08-13
- Computed from the 10-K for 2026, filed 2026-08-13
- Computed from the 10-K for 2026, filed 2026-08-13
- Computed from the 10-K for 2026, filed 2026-08-13
- Computed from the 10-K for 2026, filed 2026-08-13

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2026
Accession
0001520138-26-000332
Reported in
USD
- 10-K for 2026, filed 2026-08-13
- Computed from the 10-K for 2026, filed 2026-08-13
- 10-K for 2026, filed 2026-08-13
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.